Danaher (DHR) Earnings Analysis
Danaher (DHR) next reports earnings on 2026-10-20, consensus EPS 1.93 USD. Last quarter (2026-07-21) it beat with EPS 1.94 USD vs 1.85 USD est (+4.9%). It has beaten estimates in 6/6 recent quarters (100%). Trailing P/E 34.52.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does DHR next report earnings?
| Next earnings date | 2026-10-20 |
|---|---|
| Consensus EPS estimate | 1.93 USD |
| Revenue estimate | 6.50B |
DHR earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-07-21 | 1.94 USD | 1.85 USD | +4.9% | Beat |
| 2026-01-28 | 2.23 USD | 2.16 USD | +3.2% | Beat |
| 2025-10-21 | 1.89 USD | 1.72 USD | +9.9% | Beat |
| 2025-07-22 | 1.8 USD | 1.64 USD | +9.8% | Beat |
| 2025-01-29 | 2.14 USD | 2.14 USD | 0% | Beat |
| 2024-07-23 | 1.72 USD | 1.57 USD | +9.6% | Beat |
Beat rate: 6/6 (100%) over reported quarters with consensus data.
DHR valuation and analyst view
| Trailing P/E | 34.52 |
|---|---|
| Trailing EPS | 5.211 USD |
| Price / book | 2.40 |
| Dividend yield | 0.80% |
| Market cap | 124.80B |
| Analyst consensus | Buy (30 buy / 12 hold / 1 sell) |
| Avg price target | 214.44 USD |
Related research pages
Frequently asked questions
When is Danaher (DHR)'s next earnings date?
Danaher is next scheduled to report on 2026-10-20, with a consensus EPS estimate of 1.93 USD and revenue estimate of 6.50B.
Did DHR beat earnings last quarter?
In its 2026-07-21 report, DHR posted EPS of 1.94 USD versus a 1.85 USD estimate — a beat of 4.9%.
What is DHR's earnings track record?
Over the last 6 reported quarters with consensus data, DHR beat estimates 6 times (100%).
What is DHR's current P/E ratio and EPS?
DHR trades at a trailing P/E of 34.52 on trailing EPS of 5.211188020906908 USD.
What do analysts rate DHR?
Analyst consensus is "Buy" across 43 ratings (1 strong buy, 29 buy, 12 hold, 1 sell, 0 strong sell). Average 12-month price target: 214.44 USD.